Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

AstraZeneca Cancer Drug, Companion Test Approved

December 19, 2014 3:08 pm | by Linda A. Johnson - AP Business Writer | News | Comments

U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from AstraZeneca. Read more...                 

TOPICS:

FDA Approves Myriad's PARP Inhibitor for Ovarian Cancer

December 19, 2014 2:08 pm | News | Comments

Myriad Genetics, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for BRACAnalysis CDx to be used as the only companion diagnostic in conjunction with AstraZeneca’s drug Lynparza (olaparib). Read more...

TOPICS:

After Lung Transplant, Antiviral Drug Resistance More Likely in Cystic Fibrosis

December 19, 2014 1:50 pm | News | Comments

A drug called ganciclovir is given to lung transplant patients to protect against a life-threatening virus that is common after transplantation. Read more...                                                     

TOPICS:
Advertisement

Putting the Breaks on Cancer

December 19, 2014 1:38 pm | News | Comments

A study led by the University of Dundee, in collaboration with the University of Bath, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how it combats the effects of mutations which drive cancer development. Read more...

TOPICS:

Combo Drug Therapy Doubles Positive Effect for Women with Breast Cancer

December 19, 2014 1:20 pm | News | Comments

In a groundbreaking study that offers new hope for women with advanced breast cancer, UCLA researchers published final clinical trial results that showed the amount of time women with advanced breast cancer were on treatment without their cancer worsening was effectively doubled when they took the experimental drug palbociclib. Read more...

TOPICS:

Market for Testing On Tissues, Cells Reaches $7.5B

December 19, 2014 1:06 pm | News | Comments

Driven by new technologies and the need to discover biomarkers, the tissue and cell-based diagnostic market grew to an estimated 7.4 billion in revenues in 2013 for in vitro diagnostic (IVD) and other reagents used by clinical laboratories. Read more...

TOPICS:

Meet The Newest Surgeon General

December 19, 2014 12:37 pm | by Ryan Bushey, Associate Editor | Articles | Comments

President Obama's pick for the position turned out to be controversial. Read more...                              

TOPICS:

UN Chief Visits Ebola-Ravaged West African Nations

December 19, 2014 10:18 am | by Jonathan Paye-Layleh - Associated Press | News | Comments

United Nations Secretary-General Ban Ki-moon praised Liberia on its efforts to combat Ebola on Friday. Read more...                        

TOPICS:
Advertisement

Company Pioneers High Performance Anti-Pruritus Nanopatch

December 19, 2014 10:06 am | News | Comments

A Hong Kong company successfully developed and registered the world's first ever high-performance anti-pruritus nanopatch. Read more...                     

TOPICS:

Merck Buys Swiss Biotech Firm With Promising Cancer Drug

December 19, 2014 8:50 am | News | Comments

Merck is buying a biotech company based in Switzerland that is making a promising cancer drug. Read more...                          

TOPICS:

China Pledges to Speed Entry of U.S. Pharmaceuticals

December 19, 2014 8:37 am | by Jason Keyser - Associated Press | News | Comments

China promised Thursday to speed up imports of pharmaceuticals and medical devices from the United States. Read more...                         

TOPICS:

New Report: Hep C's Decades of Drug Research Failures, Successes

December 18, 2014 5:18 pm | by PhRMA | News | Comments

PhRMA released a new report, "Twenty-Five Years of Progress Against Hepatitis C: Setbacks and Stepping Stones," that examines the scientific challenges and setbacks researchers have faced on the path to developing new medicines with the potential to transform treatment for hepatitis C patients and how these so-called "failures" are an integral part of the drug discovery process. Read more...

TOPICS:

10 Up-and-Coming Healthcare Medical Innovations

December 18, 2014 12:10 pm | by Christina Jakubowski, Managing Editor, Bioscience Technology | Articles | Comments

The Cleveland Clinic recently unveiled their annual Top 10 Medical Innovations for 2015– a list that casts an optimistic light on up-and-coming healthcare advances that may reach consumers next year. Their number one? Read more...                         

TOPICS:

New Disease Mechanism Discovered in Lymphoma

December 18, 2014 11:34 am | by Technical University - Munich | News | Comments

Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor growth. Read more...                          

TOPICS:

Warehouse Holding Ebola Supplies in Guinea Catches Fire

December 18, 2014 11:28 am | by Boubacar Diallo - Associated Press | News | Comments

A Guinean official says a fire at a warehouse at the Conakry airport has destroyed crucial medicine to help fight Ebola. Dr. Moussa Konate, head of logistics for Guinea's Ebola response, said that the fire on Thursday morning engulfed a building holding medicine, like anti-malarials and antibiotics. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading